Patents Assigned to Thomas Jefferson University
-
Patent number: 11219118Abstract: Applications of dielectric barrier discharge (DBD) based atmospheric pressure plasma jets are often limited by the relatively small area of treatment due to their 1D configuration. This system generates 2D plasma jets permitting fast treatment of larger targets. DBD evolution starts with formation of transient anode glow, and continues with development of cathode-directed streamers. The anode glow can propagate as an ionization wave along the dielectric surface through and outside of the discharge gap. Plasma propagation is not limited to 1D geometry such as tubes, and can be organized in a form of a rectangular plasma jet, or other 2D or 3D shapes. Also described are a method for generating 2D plasma jets and use of the 2D plasma jets for cancer therapy.Type: GrantFiled: February 20, 2019Date of Patent: January 4, 2022Assignees: Drexel University, Thomas Jefferson UniversityInventors: Danil V. Dobrynin, Alexander Fridman, Abraham Lin, Vandana Miller, Adam Snook
-
Patent number: 11213225Abstract: A method of monitoring respiration with an acoustic measurement device, the acoustic measurement device having a sound transducer, the sound transducer configured to measure sound associated with airflow through a mammalian trachea, the method includes correlating the measured sound into a measurement of tidal volume and generating at least one from the group consisting of an alert and an alarm if the measured tidal volume falls outside of a predetermined range.Type: GrantFiled: May 5, 2021Date of Patent: January 4, 2022Assignees: Thomas Jefferson University, RTM Vital Signs LLCInventors: Jeffrey I Joseph, Noud Van Helmond, Marc C Torjman, Denise L Devine, Nance K Dicciani, Channy Loeum
-
Patent number: 11208472Abstract: A chimeric, humanized or single-chain antibody contains a light chain variable region containing the complementarity determining regions of SEQ ID NO: 1, SEQ ID NO:2 and SEQ ID NO:3, and a heavy chain variable region containing the complementarity determining regions SEQ ID NO:5 and SEQ ID NO:6. The antibody or antibody fragment thereof is capable of binding the C-terminal telopeptide of the ?2(I) chain of human collagen I, and is useful in the treatment of diseases or disorders associated with excessive collagen fibril.Type: GrantFiled: December 6, 2019Date of Patent: December 28, 2021Assignee: Thomas Jefferson UniversityInventors: Andrzej Fertala, Andrzej Steplewski
-
Patent number: 11186642Abstract: In one embodiment, a masked monoclonal antibody (mAb) is provided, the mAb, encoded by a nucleic acid sequence or an amino acid sequence molecule comprising a signal sequence, a masking epitope sequence, a linker sequence that is cleavable by a protease specific to a target tissue; and an antibody or a functional fragment thereof. In another embodiment, a cross-masked mAb heterodimer complex is provided, comprising a first masked mAb, comprising a first signal sequence, a first masking epitope sequence, a first linker that is cleavable by a protease specific to a target tissue, and a first antibody or fragment thereof; and a second masked mAb, comprising a second signal sequence, a second masking epitope sequence, a second linker that is cleavable by a protease specific to a target tissue, and a second antibody or fragment thereof.Type: GrantFiled: February 22, 2017Date of Patent: November 30, 2021Assignees: CITY OF HOPE, THOMAS JEFFERSON UNIVERSITYInventors: John C. Williams, Ulrich Rodeck, Joshua M. Donaldson, Csaba Kari
-
Publication number: 20210355548Abstract: The present invention relates to systems, devices and methods for diagnosing cancer. In various embodiments, the present invention provides a method for performing sequencing of 5?-htRNA in an RNA sample including obtaining a DNA library of 5?-htRNA and sequencing the DNA library of 5?-htRNAs in the RNA sample. The invention also teaches a method for quantifying 5?-htRNA half molecules in an RNA sample including (a) treating an RNA sample containing 5?-htRNAs half molecules having a 3? cyclic phosphate with a T4 polynucleotide kinase to form 3?-dephosphrylated 5?-tRNA halves, (b) 3?-AD ligating the 3?-dephosphrylated 5?-tRNA halves to form ligated RNA products, and (c) quantifying the ligated RNA products by RT-qPCR using a plurality of target primers and probes configured to simultaneously quantify at least two cP-containing 5?-tRNA half species. The treating of step (a) is simultaneously performed as one step in a single tube with the 3?-AD ligating of step (b).Type: ApplicationFiled: May 6, 2021Publication date: November 18, 2021Applicant: Thomas Jefferson UniversityInventors: Yohei Kirino, Shozo Honda, Megumi Shigematsu
-
Patent number: 11173128Abstract: An antibacterial composite material comprising at least 10% of a hemp oil, said hemp oil comprising CBD at a concentration of at least 10 mg/ml and a polymer formed by a process wherein said hemp oil and said polymer are dissolved into a solvent and said solvent is expressed through a spinneret, wherein a voltage is applied at up to 100 kV, wherein the solvent is pressed through the spinneret and forming the antibacterial composite material on a collector.Type: GrantFiled: April 26, 2019Date of Patent: November 16, 2021Assignee: Thomas Jefferson UniversityInventor: Mark Sunderland
-
Publication number: 20210275773Abstract: A system to provide circadian-friendly lighting for nighttime hospital care comprising a lighting module and a transmitter tag that interface wirelessly wherein the lighting module comprises red-shifted light spectra, which is proven to be less disruptive to melatonin production than current blue-shifted hospital lighting; wherein the light output of the devices is modulated by the proximity of a tag to the device, with light intensity increasing with closer proximity between these two components and decreasing with increased distance, thereby providing hands-free lighting to caregivers in the specific locations where they need light to perform care tasks.Type: ApplicationFiled: July 31, 2017Publication date: September 9, 2021Applicant: THOMAS JEFFERSON UNIVERSITYInventors: Lorenzo Albala, Graham Hale, Tim Bober, Bon Ku, Marcel Botha, Salih Berk Ilhan
-
Publication number: 20210260066Abstract: A method of reducing the severity of radiation induced fibrosis (RIF) by administering to a patient at least a first dose of an MeK inhibitor such as trametinib between 0.01 mg to 2.0 mg, and after said radiation procedure, administering to said patient a further dose of the MeK inhibitor between 0.01 mg and 2.0 mg after the radiation procedure.Type: ApplicationFiled: April 18, 2019Publication date: August 26, 2021Applicant: Thomas Jefferson UniversityInventors: Joel ROSENBLOOM, Edward John MACARAK
-
Patent number: 11085045Abstract: The present invention provides functional aptamer-comprising tRNA molecules, useful in the study of tRNA and ribosomal activity.Type: GrantFiled: November 16, 2016Date of Patent: August 10, 2021Assignees: Anima Biotech Inc., Thomas Jefferson UniversityInventors: Iris Alroy, Ya-Ming Hou, Howard Gamper
-
Patent number: 11077133Abstract: The present disclosure provides pharmaceutical compositions comprising nucleic acids capable of targeting IGF-1R expression in M2 cells. The present disclosure also provides methods for the selective reduction of M2 cells by targeting expression of IGF-1R in these cells. The present disclosure further provides methods for treating cancer and enhancing therapeutic by targeting expression of IGF-1R in M2 cells in patients. The pharmaceutical composition of the present invention is effective when administered systemically to subjects in need thereof. The ease of administration of the pharmaceutical composition facilitates treatment and enhances patient compliance.Type: GrantFiled: December 12, 2019Date of Patent: August 3, 2021Assignee: THOMAS JEFFERSON UNIVERSITYInventors: David W. Andrews, Douglas C. Hooper
-
Patent number: 11071476Abstract: A method of monitoring respiration with an acoustic measurement device, the acoustic measurement device having a sound transducer, the sound transducer configured to measure sound associated with airflow through a mammalian trachea, the method includes correlating the measured sound into a measurement of tidal volume and generating at least one from the group consisting of an alert and an alarm if the measured tidal volume falls outside of a predetermined range.Type: GrantFiled: August 22, 2019Date of Patent: July 27, 2021Assignees: Thomas Jefferson University, RTM Vital Signs LLCInventors: Jeffrey I Joseph, Noud Van Helmond, Marc C Torjman, Denise L Devine, Nance K Dicciani, Channy Loeum
-
Patent number: 11053405Abstract: A process for forming a conductive hemp-based ink comprising carbonizing hemp and reducing the particle size of said hemp via a milling process to between 2 and 5 microns, wherein said reduced size hemp particles are combined with at least one aqueous carrier to produce an ink, and wherein said ink is conductive.Type: GrantFiled: April 27, 2020Date of Patent: July 6, 2021Assignee: Thomas Jefferson UniversityInventor: Mark Sunderland
-
Publication number: 20210194941Abstract: A modified melanoma cell line capable of quantification of the effects of MEK inhibitors and CDK4/6 inhibitors in a quantitative, temporal and non-invasive manner both in vitro and in vivo.Type: ApplicationFiled: September 3, 2020Publication date: June 24, 2021Applicant: THOMAS JEFFERSON UNIVERSITYInventors: Andrew Aplin, Jessica Teh
-
Patent number: 11041170Abstract: The present disclosure provides methods and compositions for inducing an immune response that confers dual protection against infections by either or both of a rabies virus and a coronavirus, and/or which can be used therapeutically for an existing infection with rabies virus and/or a coronavirus to treat at least one symptom thereof and/or to neutralize or clear the infecting agents. In particular, the present disclosure provides a recombinant rabies virus vector comprising a nucleotide sequence encoding at least one coronavirus immunogenic glycoprotein fragment, as well as pharmaceutical compositions comprising the vaccine vectors.Type: GrantFiled: March 31, 2017Date of Patent: June 22, 2021Assignees: Thomas Jefferson University, The United States of America, as represented by the Secretary, Department of Health & Human Service, University of MarylandInventors: Reed F. Johnson, Matthias Schnell, Lisa E. Hensley, Christoph Wirblich, Christopher M. Coleman, Matthew B. Frieman
-
Publication number: 20210145347Abstract: A device and a signal processing method that can monitor human memory performance by recognizing and characterizing high-gamma (65-250 Hz) and beta (14-30 Hz) band oscillations in the left Brodmann Area 40 (BA40) of the brain that correspond with the strength of memory encoding or correct recall. The signal processing method detects high-gamma and beta band oscillations in the electrical signals recorded from left BA40, and quantifies the spectral content, power, duration, onset, and offset of the oscillations. The oscillation's properties are used to classify the subject's memory performance on the basis of a comparison with the subject's prior human memory performance and the properties of the corresponding oscillations. A report of the subject's current memory performance can be utilized in a closed loop brain stimulation device that serves the purpose of enhancing human memory performance.Type: ApplicationFiled: June 13, 2018Publication date: May 20, 2021Applicant: Thomas Jefferson UniversityInventors: Shennan Aibel Weiss, Zachary Waldman, Michael Sperling
-
Publication number: 20210145959Abstract: The present disclosure is directed towards chimeric glycoproteins wherein the clip region, a core region, a flap region, and a transmembrane and cytoplasmic domain are defined by starting from the amino terminus of the protein, these domains are comprised of the following amino acid residue ranges: clip, 1 through 40 to 60; core, 40 to 60 through 249 to 281; flap, 249 to 281 through 419 to 459; the transmembrane domain is comprised of amino acids 460 through 480, and the remaining amino acids 481 through 525 comprise the cytoplasmic domain; and wherein the clip, core, flap, transmembrane, and cytoplasmic domain comprise a chimeric combination of at least two lyssavirus, wherein the chimeric glycoprotein is advantageously inserted into a rabies-based vaccine vector.Type: ApplicationFiled: June 13, 2018Publication date: May 20, 2021Applicants: Thomas Jefferson University, ICAHN School of Medicine at Mount SinaiInventors: Schnell Matthias, Christine Rettew Fisher, Christoph Wirblich, Gene Tan
-
Patent number: 11006863Abstract: A method of monitoring respiration with an acoustic measurement device, the acoustic measurement device having a sound transducer, the sound transducer configured to measure sound associated with airflow through a mammalian trachea, the method includes correlating the measured sound into a measurement of tidal volume and generating at least one from the group consisting of an alert and an alarm if the measured tidal volume falls outside of a predetermined range.Type: GrantFiled: February 27, 2020Date of Patent: May 18, 2021Assignees: Thomas Jefferson University, RTM Vital Signs LLCInventors: Jeffrey I Joseph, Noud Van Helmond, Marc C Torjman, Denise L Devine, Nance K Dicciani, Channy Loeum
-
Patent number: 11001897Abstract: The present invention relates to systems, devices and methods for diagnosing cancer. In various embodiments, the present invention provides a method for quantifying a 5?-htRNA; a method for quantifying a 3?-htRNA; a method for obtaining a DNA library of 5?-htRNAs and a DNA library of 5?-htRNAs obtained therefrom; and a method for obtaining a DNA library of 3?-htRNAs and a DNA library of 3?-htRNAs obtained therefrom. The invention also teaches a method for determining the presence or absence of a cancer cell in a biological sample; a method of diagnosing cancer in a subject; and a method of prognosing cancer in a subject.Type: GrantFiled: February 26, 2020Date of Patent: May 11, 2021Assignee: Thomas Jefferson UniversityInventors: Yohei Kirino, Shozo Honda
-
Patent number: 11000212Abstract: A method of monitoring respiration with an acoustic measurement device, the acoustic measurement device having a sound transducer, the sound transducer configured to measure sound associated with airflow through a mammalian trachea, the method includes correlating the measured sound into a measurement of tidal volume and generating at least one from the group consisting of an alert and an alarm if the measured tidal volume falls outside of a predetermined range.Type: GrantFiled: August 18, 2020Date of Patent: May 11, 2021Assignees: Thomas Jefferson University, RTM Vital Signs LLCInventors: Jeffrey I Joseph, Noud Van Helmond, Marc C Torjman, Denise L Devine, Nance K Dicciani, Channy Loeum
-
Patent number: 11000195Abstract: An implantable vital sign sensor including a housing including a first portion, the first portion defining a first open end, a second open end opposite the first end, and a lumen there through, the first portion being sized to be implanted substantially entirely within the blood vessel wall of the patient. A sensor module configured to measure a blood vessel blood pressure waveform is included, the sensor module having a proximal portion and a distal portion, the distal portion being insertable within the lumen and the proximal portion extending outward from the first open end.Type: GrantFiled: November 17, 2016Date of Patent: May 11, 2021Assignees: Thomas Jefferson University, RTM Vital Signs LLCInventors: Jeffrey I. Joseph, Apurva Jain, Jonathan Goettler, Nance Dicciani, Denise Devine